Diabetes and COVID-19: Short- and Long-Term Consequences.
Journal
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
ISSN: 1439-4286
Titre abrégé: Horm Metab Res
Pays: Germany
ID NLM: 0177722
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
pubmed:
21
6
2022
medline:
12
8
2022
entrez:
20
6
2022
Statut:
ppublish
Résumé
When the corona pandemic commenced more than two years ago, it was quickly recognized that people with metabolic diseases show an augmented risk of severe COVID-19 and an increased mortality compared to people without these comorbidities. Furthermore, an infection with SARS-CoV-2 has been shown to lead to an aggravation of metabolic diseases and in single cases to new-onset metabolic disorders. In addition to the increased risk for people with diabetes in the acute phase of COVID-19, this patient group also seems to be more often affected by long-COVID and to experience more long-term consequences than people without diabetes. The mechanisms behind these discrepancies between people with and without diabetes in relation to COVID-19 are not completely understood yet and will require further research and follow-up studies during the following years. In the current review, we discuss why patients with diabetes have this higher risk of developing severe COVID-19 symptoms not only in the acute phase of the disease but also in relation to long-COVID, vaccine breakthrough infections and re-infections. Furthermore, we discuss the effects of lockdown on glycemic control.
Identifiants
pubmed: 35724689
doi: 10.1055/a-1878-9566
pmc: PMC9363150
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
503-509Subventions
Organisme : 288034826,314061271
ID : Deutsche Forschungsgemeinschaft
Informations de copyright
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
BMJ Open. 2021 Jul 22;11(7):e052451
pubmed: 34301671
Mol Psychiatry. 2020 Aug;25(8):1611-1617
pubmed: 32382135
Diabetol Metab Syndr. 2021 Mar 01;13(1):23
pubmed: 33648564
J Clin Transl Endocrinol. 2022 Mar;27:100285
pubmed: 34900602
Biomed Pharmacother. 2021 Apr;136:111193
pubmed: 33461019
Diabetes Res Clin Pract. 2021 Oct;180:109066
pubmed: 34563586
Diabetes. 2020 Oct;69(10):2048-2053
pubmed: 32778570
Acta Diabetol. 2021 Dec;58(12):1603-1611
pubmed: 34159476
Diabetes Metab Syndr. 2021 May-Jun;15(3):869-875
pubmed: 33892403
Cold Spring Harb Perspect Biol. 2014 Jan 01;6(1):
pubmed: 24384568
JCI Insight. 2021 Aug 23;6(16):
pubmed: 34241597
Am J Physiol Lung Cell Mol Physiol. 2015 Aug 1;309(3):L262-70
pubmed: 26047641
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1009-e1019
pubmed: 34718627
J Fungi (Basel). 2021 Aug 07;7(8):
pubmed: 34436180
J Affect Disord. 2012 Oct;142 Suppl:S8-21
pubmed: 23062861
Mycoses. 2021 Dec;64(12):1452-1459
pubmed: 34133798
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
Mycopathologia. 2021 May;186(2):289-298
pubmed: 33544266
Clin Infect Dis. 2012 Feb;54 Suppl 1:S16-22
pubmed: 22247441
Nat Metab. 2021 Mar;3(3):289-292
pubmed: 33633407
Mol Biol Rep. 2022 Apr;49(4):3349-3356
pubmed: 35064406
J Korean Med Sci. 2021 Jan 18;36(3):e21
pubmed: 33463095
Diabetologia. 2006 May;49(5):837-45
pubmed: 16520921
Acta Diabetol. 2021 Feb;58(2):231-237
pubmed: 33067723
Crit Care. 2012 Jul 24;16(4):R134
pubmed: 22827994
Lancet Infect Dis. 2021 Nov;21(11):1485-1486
pubmed: 34506735
Nat Med. 2021 Sep;27(9):1607-1613
pubmed: 34163090
IDCases. 2021;26:e01328
pubmed: 34777995
Diabetologia. 2015 Dec;58(12):2851-60
pubmed: 26350612
Sci Total Environ. 2020 Jul 10;725:138277
pubmed: 32278175
Curr Diab Rep. 2022 Feb;22(2):53-63
pubmed: 35171448
Arch Med Res. 2021 Aug;52(6):575-581
pubmed: 33962805
N Engl J Med. 2021 Apr 15;384(15):1412-1423
pubmed: 33626250
Med Hypotheses. 2020 Jul;140:109776
pubmed: 32344313
World J Diabetes. 2015 Jul 25;6(8):1073-81
pubmed: 26240704
Nat Metab. 2021 Jun;3(6):774-785
pubmed: 34035524
Nat Rev Endocrinol. 2022 Feb;18(2):75-76
pubmed: 34873287
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102235
pubmed: 34384972
Obes Med. 2020 Sep;19:100290
pubmed: 32844132
Indian J Ophthalmol. 2021 Feb;69(2):244-252
pubmed: 33463566
PLoS Pathog. 2017 Aug 3;13(8):e1006408
pubmed: 28771587
Curr Opin Rheumatol. 2018 Jan;30(1):72-78
pubmed: 28937414
Acta Diabetol. 2020 Jul;57(7):779-783
pubmed: 32506195
Acta Diabetol. 2019 Jun;56(6):631-650
pubmed: 30903433
Front Endocrinol (Lausanne). 2020 Dec 07;11:595735
pubmed: 33424771
Lancet. 2020 Mar 21;395(10228):e52
pubmed: 32171074
J Infect. 2021 Jul;83(1):1-16
pubmed: 33992686
Sci Rep. 2022 Jan 26;12(1):1438
pubmed: 35082344
Br J Clin Pharmacol. 2022 Jun;88(6):2642-2656
pubmed: 35122284
Nutrients. 2021 Nov 26;13(12):
pubmed: 34959805
BMC Infect Dis. 2022 Jan 27;22(1):93
pubmed: 35086489
Clin Microbiol Infect. 2022 May;28(5):657-666
pubmed: 35124265
JAMA Netw Open. 2021 May 3;4(5):e2111417
pubmed: 34037731
Diabetes Metab Res Rev. 2022 Jan;38(1):e3508
pubmed: 34990520
Lancet Respir Med. 2021 Dec;9(12):1439-1449
pubmed: 34599903
Diabet Med. 2021 Jul;38(7):e14562
pubmed: 33772867
Front Endocrinol (Lausanne). 2021 Jan 13;11:600439
pubmed: 33519709
J Clin Transl Endocrinol. 2022 Mar;27:100284
pubmed: 34877261
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
Nat Rev Endocrinol. 2021 Mar;17(3):135-149
pubmed: 33479538
Diabet Med. 2019 Aug;36(8):961-969
pubmed: 31127631
J Fungi (Basel). 2021 Apr 15;7(4):
pubmed: 33920755
Indian J Ophthalmol. 2021 Jun;69(6):1563-1568
pubmed: 34011742
Front Immunol. 2021 Jun 30;12:686029
pubmed: 34276671
Nat Med. 2018 Aug;24(8):1121-1127
pubmed: 29967351
BMC Pediatr. 2022 Jan 19;22(1):48
pubmed: 35045807
Curr Opin Immunol. 2011 Dec;23(6):732-8
pubmed: 21917438
Pharmacol Ther. 2021 May;221:107750
pubmed: 33275999
Acta Diabetol. 2022 Jan;59(1):95-104
pubmed: 34495396
Diabetes Metab Res Rev. 2019 May;35(4):e3132
pubmed: 30693639
Lancet Diabetes Endocrinol. 2022 Mar;10(3):221-230
pubmed: 35114136
MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):59-65
pubmed: 35025851
Diabetes Obes Metab. 2022 Jun;24(6):1176-1179
pubmed: 35112782
J Diabetes Investig. 2021 Sep;12(9):1708-1717
pubmed: 33539665
BMJ Case Rep. 2021 Jul 29;14(7):
pubmed: 34326123
Am J Phys Med Rehabil. 2022 Jan 1;101(1):48-52
pubmed: 34686631
Lancet Diabetes Endocrinol. 2021 Nov;9(11):786-798
pubmed: 34619105
J Fungi (Basel). 2018 Apr 06;4(2):
pubmed: 29642408
Indian J Ophthalmol. 2021 Jul;69(7):1645-1647
pubmed: 34146000
Diabetes. 2018 Jun;67(6):1035-1042
pubmed: 29784651
Curr Med Res Opin. 2022 Mar;38(3):357-364
pubmed: 35057687
Crit Care. 2021 Dec 17;25(1):437
pubmed: 34920750
Nat Commun. 2021 Jun 10;12(1):3534
pubmed: 34112801
Curr Diab Rep. 2014 Jun;14(6):491
pubmed: 24743941
J Diabetes. 2014 Jan;6(1):9-20
pubmed: 24103089
Discov Ment Health. 2022;2(1):5
pubmed: 35253006
J Clin Psychiatry. 2013 Jan;74(1):31-7
pubmed: 23419223
Endocrine. 2021 Sep;73(3):499-506
pubmed: 34244903
Diabetes Metab Syndr. 2021 Nov-Dec;15(6):102302
pubmed: 34626924
Nat Metab. 2021 Feb;3(2):149-165
pubmed: 33536639
Curr Res Microb Sci. 2021 Dec;2:100057
pubmed: 34396355
Clin Exp Med. 2020 Nov;20(4):493-506
pubmed: 32720223
Diabetes Res Clin Pract. 2014 Aug;105(2):141-50
pubmed: 24798950
Acta Diabetol. 2021 Jun;58(6):771-778
pubmed: 33582839